UB PhD student named ACCP Student & Trainee and Early-stage Professional Abstract Award Winner

By Samantha Nebelecky

Published September 3, 2026

Brent Boleslav, MS, PhD student in the UB Department of Pharmaceutical Sciences.

Brent Boleslav, MS, a PhD student in the Division of Pharmacokinetics, Pharmacodynamics, and Systems Pharmacology at the University at Buffalo (UB) Department of Pharmaceutical Sciences, has been named a recipient of the American College of Clinical Pharmacology (ACCP) Student & Trainee and Early-stage Professional Abstract Award.

Print
“It's a real honor to be selected and have my research recognized. It gives me a great opportunity to share my work, attend this conference, and make connections as I look to finish my dissertation and move towards the next stage of my career.”
Brent Boleslav, MS, PhD student, Department of Pharmaceutical Sciences
UB School of Pharmacy and Pharmaceutical Sciences

The award recognizes outstanding research abstracts submitted by students, trainees and early-stage professionals. Recipients will be honored during the 2026 ACCP Annual Meeting and receive a trophy, an honorarium, complimentary meeting registration and up to $500 in reimbursable travel expenses.

Boleslav will attend the 2026 ACCP Annual Meeting in Bethesda, MD, Sept. 26-29, where he will present his award-winning abstract.

Research in pharmacometric and systems pharmacology models

Boleslav’s research focuses on developing pharmacometric and systems pharmacology models that quantify how drugs behave in combination. He uses those models to predict clinical response and support dose selection. 

He was recognized for his abstract titled, “Translational PK/PD Modeling for Prediction of Clinical Response to TAS102 Plus Talazoparib in Advanced Colorectal Cancer from Patient-Derived Xenografts.” In collaboration with Roswell Park Comprehensive Cancer Center, Boleslav utilized patient-derived xenografts to develop a mathematical model that quantifies the efficacy of a novel drug combination currently in clinical trials to help understand the heterogeneity in response to the combination. The team then used the model to predict effective drug concentrations in humans, and the results supported dose selection for further development. 

“It's a real honor to be selected and have my research recognized,” said Boleslav. “It gives me a great opportunity to share my work, attend this conference, and make connections as I look to finish my dissertation and move towards the next stage of my career. “

Boleslav extended his gratitude to his faculty mentor and research collaborators. “I would like to thank my advisor, Donald Mager, PharmD, PhD, chair of pharmaceutical sciences, who has given me great mentorship throughout this year and my time here at UB. I'd also like to acknowledge our collaborators at Roswell Park for their help and support throughout this research.” 

For over 140 years, the University at Buffalo School of Pharmacy and Pharmaceutical Sciences has continually been a leader in the education of pharmacists and pharmaceutical scientists, renowned for innovation in clinical practice and research. The school is accredited by the American Council of Pharmaceutical Education and is the No. 1 ranked school of pharmacy in New York State and No. 19 in the United States by U.S. News & World Report.

Contact Us

Do you have questions or comments for the Office of the Provost? Let us know your thoughts and we’ll be happy to get back to you.

Contact Us>

OUR RESEARCH MAKES LIFE BETTER

graduate student inspects a sample in a laboratory.

As one of the nation's leading public research universities, UB has been changing the world through its research and scholarship for decades. Today, UB continues to deliver ideas, discoveries and innovations for a safer, healthier and brighter future.

Explore UB’s pioneering research>